Physical Medicine & Rehabilitation · Pottstown, PA
NPI
1801810247
Since 2006
Specialty
Physical Medicine & Rehabilitation
Code 208100000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
1603 E High St, Suite A
Pottstown, PA, 19464
Phone (610) 970-4700
Groups this clinician bills Medicare through
Medicare paid, 2024
$290K
12,637 services
Medicare patients, 2024
524
Average age 74
Drug cost, 2024
$59K
571 prescriptions
Company payments, 2025
$1,165
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christiopher C Dankmyer was code J0897 (injection, denosumab, 1 mg), 2,280 times for 37 patients. In total Christiopher C Dankmyer billed 12,637 services in 47 codes, and Medicare paid $290K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 2,280 | 37 | $21.36 | $49K |
| J7322 Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg | Office | 1,632 | 16 | $13.50 | $22K |
| J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | Office | 1,472 | 15 | $13.64 | $20K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 908 | 89 | $0.09 | $80.27 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 742 | 310 | $12.34 | $9,153 |
| 99214 Office E&M - Established | Office | 728 | 332 | $95.73 | $70K |
| 95886 Electrical Nerve Conductivity | Office | 271 | 138 | $77.22 | $21K |
| 95913 Electrical Nerve Conductivity | Office | 137 | 132 | $224.74 | $31K |
| 20611 Joint Injection | Office | 119 | 45 | $91.72 | $11K |
| 99213 Office E&M - Established | Office | 109 | 86 | $68.86 | $7,505 |
| 76942 Ultrasound - Nonspecific | Office | 70 | 50 | $44.75 | $3,132 |
| 95870 Electrical Nerve Conductivity | Office | 65 | 49 | $62.83 | $4,084 |
| 99215 Office E&M - Established | Office | 52 | 41 | $138.45 | $7,199 |
| 99204 Office E&M - New | Office | 50 | 50 | $124.67 | $6,234 |
| 20553 Musculoskeletal | Office | 46 | 33 | $46.35 | $2,132 |
By year: 2022 $242K for 7,317 services; 2023 $231K for 8,347 services; 2024 $290K for 12,637 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christiopher C Dankmyer prescribed most often to Medicare patients was Gabapentin, with 140 prescriptions and refills. In total Christiopher C Dankmyer wrote 571 Medicare prescriptions that cost $59K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 140 | 194 | 29 | $1,132 |
| Tizanidine Hcl Generic | 60 | 70 | 16 | $428 |
| Tramadol Hcl Generic | 50 | 50 | 12 | $231 |
| Meloxicam Generic | 35 | 41 | 17 | $84.57 |
| Nabumetone Generic | 34 | 38 | 14 | $306 |
| Diazepam Generic | 27 | 27 | 15 | $16.8 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 26 | 26 | Under 11 | $247 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 25 | 25 | Under 11 | $460 |
| Celecoxib Generic | 22 | 22 | Under 11 | $703 |
| Botox Onabotulinumtoxina | 17 | 49 | Under 11 | $24K |
| Ms Contin Morphine Sulfate | 12 | 12 | Under 11 | $5,558 |
| Duloxetine Hcl Generic | 11 | 11 | Under 11 | $43.89 |
| Methylprednisolone Generic | 11 | 11 | Under 11 | $37.33 |
| Xtampza Er Oxycodone Myristate | 11 | 11 | Under 11 | $7,250 |
Brand drugs: 71 claims; generic drugs: 500 claims; opioid claims: 162.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christiopher C Dankmyer $1,165 ($1,165 in general payments such as food, travel and fees) from 20 companies. The largest payer was Averitas Pharma Inc. with $278.
| Company | Payments | Amount |
|---|---|---|
| Averitas Pharma Inc. | 7 | $278 |
| Abbvie Inc. ABBV | 6 | $207 |
| Ferring Pharmaceuticals Inc. | 4 | $111 |
| Saluda Medical Americas, Inc. | 2 | $97.54 |
| TerSera Therapeutics LLC | 2 | $74.03 |
| Scilex Pharmaceuticals Inc. | 2 | $49.65 |
| Globus Medical, Inc. GMED | 2 | $48.61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $42.52 |
| Vertex Pharmaceuticals Incorporated VRTX | 2 | $32.81 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $29.05 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.